August 2021 FDA Recall Carbamazepine by The Harvard Drug Group
D-0807-2021 - Failed Dissolution Specifications
This Class II drug recall was voluntarily initiated by The Harvard Drug Group on August 6, 2021 for the product Carbamazepine. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed in NC and the recall is currently terminated.
Recall Number: D-0807-2021
Failed Dissolution Specifications
08-06-2021
09-29-2021
4 Cartons of 100 count each
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
The Harvard Drug Group
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
NC
11-08-2022
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Carbamazepine 200mg Tablets, USP, 200 mg, 100 Count Unit Dose Cartons, Rx only, Manufactured by: Torrent Pharmaceuticals Ltd., Bharuch-392130, India; Manufactured for: Torrent Pharma, Inc., Basking Ridge, NJ 07920; Distributed by: MAJOR PHARMACEUTICALS, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152 USA. NDC 0904-6172-61
Batch or Lot Expiration Information
Lot# Lot R01562; Exp. 10/2022